SCHEMBL23571306

SCHEMBL23571306

CCN(CC)c1ccc(C(=O)c2ccccc2C(=O)NCCCCCN2C(=O)C=CC2=O)c(O)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.54
▸ MEN1 O00255 1/20 0.54
▸ KMT2A Q03164 1/20 0.54
▸ SMN1; SMN2 Q16637 1/20 0.54
▸ ALDH1A1 P00352 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ NAAA Q02083 2/20 0.42
▸ APP P05067 9/20 0.42
▸ ALOX5 P09917 1/20 0.40
▸ TSHR P16473 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ DNMT1 P26358 1/20 0.38
▸ DNMT3L Q9UJW3 1/20 0.38
▸ DNMT3A Q9Y6K1 1/20 0.38
▸ OPRM1 P35372 1/20 0.37
▸ OPRD1 P41143 1/20 0.37
▸ OPRK1 P41145 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10098743 0.89 SMN1; SMN2 (0.67) L3MBTL1MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL14191554 0.84 SMN1; SMN2 (0.61) L3MBTL1MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL4282212 0.84 L3MBTL1 (0.67) L3MBTL1MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL18671198 0.84 SMN1; SMN2 (0.72) L3MBTL1MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL669854 0.83 L3MBTL1 (0.54) L3MBTL1MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL23571278 0.83 L3MBTL1 (0.54) L3MBTL1MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL22430334 0.79 SMN1; SMN2 (0.54) L3MBTL1MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL13808697 0.79 L3MBTL1 (0.58) L3MBTL1MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL23571724 0.78 MEN1 (0.55) L3MBTL1MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL4230630 0.78 SMN1; SMN2 (0.57) L3MBTL1MEN1KMT2ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230323028-A1 ADHESIVE PHOTOPROTECTIVE COMPOUNDS AND USES THEREOF SKINOSIVE (FR) 2023-10-12 — — US disclosed
WO-2021123116-A1 ADHESIVE PHOTOPROTECTIVE COMPOUNDS AND USES THEREOF SKINOSIVE (FR) 2021-06-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230323028-A1 ADHESIVE PHOTOPROTECTIVE COMPOUNDS AND USES THEREOF ICAM1, CDH1, VCAM1 L3MBTL1 2580/4885MEN1 1875/4885KMT2A 2352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback